AHC yields 403.04% · JNJ yields 2.13%● Live data
📍 AHC pulled ahead of the other in Year 1
Combined, AHC + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AHC + JNJ for your $10,000?
A.H. Belo Corporation, together with its subsidiaries, operates as a local news and information publishing company primarily in Texas. The company publishes The Dallas Morning News, a newspaper; Briefing newspaper; and Al Dia, a Spanish-language newspaper, as well as operates related websites and mobile applications. It also offers commercial printing, distribution, direct mail, and shared mail packaging services; and auto dealerships advertising services on the cars.com platform. In addition, the company provides digital marketing services, such as multi-channel marketing solutions through subscription sales of its cloud-based software; digital and marketing analytics, search engine marketing, and other marketing related services; social media account management and content marketing services; and multi- channel digital advertising and marketing services campaigns, as well as marketing and promotional products for businesses. A.H. Belo Corporation was founded in 1842 and is headquartered in Dallas, Texas.
Full AHC Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.